IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Onconova Therapeutics Inc

CUSIP: 68232V908 | 2 institutional holders

Quarters

Q3 2015Q4 2014Q3 2014Q2 2014Q1 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile